Vincent Rajkumar/X
Dec 6, 2025, 06:32
Vincent Rajkumar: mSMART Risk Stratification of Myeloma
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester and Editor‑in‑Chief at Blood Cancer Journal, shared a post on X:
”Ahead of ASH25 here is our latest mSMART risk stratification of myeloma. Bookmark!
-Incorporates latest IMS IMWG high risk definition
-Defines double-hit myeloma
-Additional high risk categories.”
Find the full coverage of ASH25 in Hemostasis Today.
-
Oct 25, 2026, 16:45Shauna Riley։ First Guidelines for Hemoglobin SC Disease
-
Oct 25, 2026, 16:26Heghine Khachatryan: Patient Safety and Clinical Judgment in Platelet Transfusion Decisions
-
Oct 25, 2026, 16:13Funmi (Vanessa) Ullam: From Lived Experience to Research and Innovation in Sickle Cell Care
-
Oct 25, 2026, 15:13Franky Biles: Celebrating Diversity and Driving Inclusion Through Representation
-
Oct 25, 2026, 14:47Siddharth Mittal: A Sheet-Like Effluent Deposit During Plasma Exchange in iTTP
-
Oct 25, 2026, 14:16Alejandro González Veliz: Can Factor XIa Inhibition Prevent Recurrent Ischemic Events Without Increasing Bleeding?
-
Oct 25, 2026, 13:0910 Posts Not to Miss This Week
-
Oct 25, 2026, 13:02Thomas Dayspring: Advancing Cardiovascular Risk Assessment Through Multidisciplinary Lipid Care
-
Oct 25, 2026, 12:46Ahmar U. Zaidi: RISE UP Study on Sickle Cell Disease